2018 was a banner year for the United States cannabis industry and 2019 will most likely be even more significant. During the last year, we have seen several significant medical cannabis markets open on the East Coast of the United States and we expect these markets to record massive growth going forward.
Medical cannabis markets such as Florida and New York represent burgeoning opportunities and we expect to see recreational markets in Massachusetts and Michigan to generate significant revenue.
During the last few years, we have been laser focused on the United States cannabis market and have been researching the companies that are focused on this opportunity. One company that we have been especially favorable on is Liberty Health Sciences (LHS.CN) (LHSIF) and this is a company that investors should be watching.
Liberty Health: Has Been Nothing Short of an Execution Story
When looking at Liberty Health Sciences, it is very tough to not get overly excited and we want to discuss this opportunity in more detail. First, the company has attractive leverage to the Florida, Massachusetts, and Ohio markets. Second, the valuation is attractive and Liberty Health trades at a significant discount to its peers. Finally, the company is led by a management team that has been executing flawlessly and has a proven track record of success.
The leverage the East Coast of the United States is significant, and Liberty Health is in the middle of a major expansion. The Florida medical marijuana market represents a massive opportunity and the company is allowed to open up to 30 dispensaries in the state. Currently, Liberty Health operates seven dispensaries and six delivery hubs in Florida. The company expects to open another seven dispensaries by the end of February for a total of 14 dispensaries across Florida, including locations in Miami, Boca Raton and Gainesville.
Liberty Health has been executing on the Ohio medical marijuana market and we are favorable on the growth prospects going forward. The company as well as its joint venture partner, the Schottenstein Group, expects to open their dispensary in Dayton, Ohio by the end of March. The companies have secured a 10,000 square foot processing facility, which will be used for extraction, refining, formulation and packaging. The processing facility is expected to open in the spring of 2019, and we expect this to prove to be a significant value driver for the company.
An Opportunity Worth Watching
During the last month, Liberty Health Sciences has rallied well off its lows and we think this company has significant room for growth. In December, negative reports were issued on Aphria (APHA.TO) (APHA) and this put considerable pressure on Liberty Health Sciences. Although the reports pertained to Aphria, the market responded negatively to Liberty and the shares plunged lower.
This weakness was not based on fundamentals and it created a great opportunity for investors to invest in a high-quality cannabis company that has massive growth potential. Liberty Health is well capitalized and is in the middle of a major expansion. The company has significant catalysts for growth and is well positioned to capitalize on the United States cannabis market.
When it comes to investing in cannabis companies, investors want to focus on companies that have been executing on previously announced initiatives, that are well capitalized and well positioned for growth, and that are led by a management team that is focused on creating value for its shareholders. We believe that Liberty Health possess these traits and is a company with significant upside potential.
We will continue to monitor this leading United States cannabis company and are favorable on the growth prospects going forward. To be added to our Liberty Health Sciences contact list, please email firstname.lastname@example.org.
Pursuant to an agreement between StoneBridge Partners LLC and Liberty Health Sciences Inc. we have been hired for a period of 90 days beginning January 7 , 2019 and ending April 7, 2019 to publicly disseminate information about (LHS) including on the Website and other media including Facebook and Twitter. We are being paid $6,750 per month for a period of 3 months. We own zero shares of (LHS), which we purchased in the open market. We plan to sell the “ZERO” shares of (LHS) that we hold during the time the Website and/or Facebook and Twitter Information recommends that investors or visitors to the website purchase without further notice to you. We may buy or sell additional shares of (LHS) in the open market at any time, including before, during or after the Website and Information, provide public dissemination of favorable Information